Business Information
The group's principal activities are to develop, manufacture and distribute cardiovascular medical devices for the global cardiac rhythm management, cardiac surgery and cardiology and vascular access therapy areas. The group's principal products in each of these therapy areas are bradycardia pacemaker systems, tachycardia implantable cardioverter defibrillator systems, electrophysiology catheters, mechanical and tissue heart valves, valve repair products vascular closure devices, angiography catheters, guidewires and hemostasis introducers. These products are marketed primarily in the United States, Europe and Japan and also sold in Canada, Latin America, Australia, New Zealand and the Asia-pacific region. On 01-Apr-2003, the group acquired getz bros co ltd (getz Japan), net assets of getz bros & co (aust) pty limited and medtel pty limited. On 08-Jun-2004, it also acquired epicor medical inc.
|
|
Name |
Title
|
Email
|
| Daniel Starks | Chmn., CEO, Pres. | N/A | | Christopher Chavez | Pres. - Neuromodulation Division | N/A | | Denis Gestin | Pres. - SJM Europe | N/A | | Eric Fain | Pres. - Cardiac Rhythm Management Division | N/A | | George Fazio | Pres. - Cardiovascular Division | N/A |
|
|
Year |
Sales |
Net Income |
| 2005 | 2,915,280 | 393,490 | | 2004 | 2,294,173 | 409,934 | | 2006 | 3,302,447 | 548,251
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
